KR100651337B1 - Method for preparing an optical active 1,4-benzodioxan-2-carboxylic compounds by enzymatic method - Google Patents

Method for preparing an optical active 1,4-benzodioxan-2-carboxylic compounds by enzymatic method Download PDF

Info

Publication number
KR100651337B1
KR100651337B1 KR1020020071242A KR20020071242A KR100651337B1 KR 100651337 B1 KR100651337 B1 KR 100651337B1 KR 1020020071242 A KR1020020071242 A KR 1020020071242A KR 20020071242 A KR20020071242 A KR 20020071242A KR 100651337 B1 KR100651337 B1 KR 100651337B1
Authority
KR
South Korea
Prior art keywords
benzodioxane
aspergillus
carboxylic acid
organic solvent
carboxypiperazine
Prior art date
Application number
KR1020020071242A
Other languages
Korean (ko)
Other versions
KR20040042665A (en
Inventor
정기남
김종근
조남륜
임종호
Original Assignee
에스케이 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스케이 주식회사 filed Critical 에스케이 주식회사
Priority to KR1020020071242A priority Critical patent/KR100651337B1/en
Publication of KR20040042665A publication Critical patent/KR20040042665A/en
Application granted granted Critical
Publication of KR100651337B1 publication Critical patent/KR100651337B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

본 발명은 효소적 방법에 의한 광학활성 1,4-벤조디옥산-2-카르복시 화합물의 제조방법에 관한 것으로, 좀 더 구체적으로는 라세믹 1,4-벤조디옥산-2-카르복시피페라진(1,4-benzodioxan-2-carboxypiperazine) 화합물을 프로테아제 효소를 이용하여 선택적으로 가수분해시키는 효소적 방법에 의한 S-1,4-벤조디옥산-2-카르복시피페라진 및 R-1,4-벤조디옥산-2-카르복실산의 제조방법에 관한 것이다. 본 발명의 제조방법은 프로테아제 효소를 사용하여 제조공정이 간단하며, 광학순도 및 수율이 높아 산업상 매우 유용하다.The present invention relates to a method for preparing an optically active 1,4-benzodioxane-2-carboxy compound by enzymatic method, more specifically racemic 1,4-benzodioxane-2-carboxypiperazin ( S-1,4-benzodioxane-2-carboxypiperazine and R-1,4-benzo by enzymatic method of selectively hydrolyzing 1,4-benzodioxan-2-carboxypiperazine) compound using protease enzyme A method for producing dioxane-2-carboxylic acid. The production method of the present invention is simple in the production process using the protease enzyme, high optical purity and yield is very useful industrially.

1,4-벤조디옥산-2-카르복시피페라진, 1,4-벤조디옥산-2-카르복실산, 라세믹체, 가수분해, 프로테아제, 아스퍼질러스, 스트렙토마이세스1,4-benzodioxane-2-carboxypiperazin, 1,4-benzodioxane-2-carboxylic acid, racemic body, hydrolysis, protease, aspergillus, streptomyces

Description

효소적 방법에 의한 광학활성 1,4-벤조디옥산-2-카르복시 화합물의 제조방법{Method for preparing an optical active 1,4-benzodioxan-2-carboxylic compounds by enzymatic method}Method for preparing an optical active 1,4-benzodioxan-2-carboxylic compounds by enzymatic method}

본 발명은 효소적 방법에 의한 광학활성 1,4-벤조디옥산-2-카르복시 화합물의 제조방법에 관한 것으로, 좀 더 상세하게는 라세믹 1,4-벤조디옥산-2-카르복시피페라진(1,4-benzodioxan-2-carboxypiperazine)을 버퍼(buffer) 용액에 용해시킨 후, 미생물 유래의 프로테아제를 작용시켜 하나의 아미드를 선택적으로 가수분해시키는 효소적 방법에 의한 광학활성 1,4-벤조디옥산-2-카르복시피페라진(1,4-benzodioxan-2-carboxypiperazine) 및 1,4-벤조디옥산-2-카르복실산(1,4-benzodioxan-2-carboxylic acid)의 제조방법에 관한 것이다.The present invention relates to a method for preparing an optically active 1,4-benzodioxane-2-carboxy compound by enzymatic method, more specifically racemic 1,4-benzodioxane-2-carboxypiperazin ( 1,4-benzodioxan-2-carboxypiperazine) is dissolved in a buffer solution, and then optically active 1,4-benzodi by an enzymatic method of selectively hydrolyzing one amide by acting a protease derived from a microorganism. It relates to a method for producing oxane-2-carboxypiperazin (1,4-benzodioxan-2-carboxypiperazine) and 1,4-benzodioxane-2-carboxylic acid (1,4-benzodioxan-2-carboxylic acid). .

광학 활성 1,4-벤조디옥산-2-카르복시피페라진 또는 1,4-벤조디옥산-2-카르복실산은 고혈압 치료제인 카두라(Cardura)의 합성에 필요한 중간체로 사용되고 있다. 카두라는 1988년 화이자(Pfizer)사에 의해 출시된 고혈압 치료제로서 화학명은 (±-독사조신 메실레이트(Doxazosin mesylate)이고, 하기 화학식 1로 표시되며, 현재는 라세믹체로서 판매되고 있다. Optically active 1,4-benzodioxane-2-carboxypiperazin or 1,4-benzodioxane-2-carboxylic acid is used as an intermediate for the synthesis of Cardura, a therapeutic agent for hypertension. Kadura is a hypertension therapeutic released by Pfizer in 1988, and its chemical name is (± -doxazosin mesylate), and is represented by the following Chemical Formula 1, and is currently sold as a racemic body.                         

Figure 112002037817697-pat00001
Figure 112002037817697-pat00001

(±)-독사조신 메실레이트의 제조방법에는 다음과 같은 방법이 있다.The production method of (±) -doxazosin mesylate includes the following methods.

화이자사가 1977년 발표한 영국특허 제2007656호에는 카테콜로부터 제조된 1,4-벤조디옥산-2-카르복시피페라진과 바닐린으로부터 제조된 헤테로 아로마틱 화합물의 결합으로 라세믹 독사조신을 제조하고 다시 메탄술폰산과의 중화반응으로 메탄술폰산염을 제조하는 방법이 기재되어 있다.U.S. Patent No. 2007656 published by Pfizer in 1977 prepares racemic doxazosin with a combination of 1,4-benzodioxane-2-carboxypiperazin made from catechol and a heteroaromatic compound made from vanillin and again methanesulfonic acid. A method for preparing methanesulfonic acid salt by neutralization with is described.

최근 상기 독사조신이 전립선비대증(BPH, Benign Prostatic Hyperplasia) 치료에도 효과가 있다는 것이 확인되었으며, 또한 전 임상실험 결과 독사조신의 (S)-이성질체가 라세믹체에 비해 무기력증, 현기증 등의 부작용이 적고, BPH 치료에 효과가 크다는 것이 확인되어 최근 (S)-독사조신의 임상 연구가 진행되고 있다. Recently, it has been confirmed that the doxazosin is effective for the treatment of Benign Prostatic Hyperplasia (BPH). It is confirmed that the effect is large, and recently, a clinical study of (S) -doxazosin is in progress.

(S)-독사조신의 합성을 위한 주요 광학활성 중간체는 하기 화학식 2로 표시되는 (S)-1,4-벤조디옥산-2-카르복실산과 하기 화학식 3으로 표시되는 (S)-1,4-벤조디옥산-2-카르복시피페라진이 있으며, 후자는 전자를 피페라진 염산염(piperazine monochloride)과 반응시키면 쉽게 합성시킬 수 있다. The main optically active intermediates for the synthesis of (S) -doxazosin are (S) -1,4-benzodioxane-2-carboxylic acid represented by the following formula (2) and (S) -1,4 represented by the following formula (3) -Benzodioxane-2-carboxypiperazin, the latter can be easily synthesized by reacting the former with piperazine monochloride.                         

Figure 112002037817697-pat00002
Figure 112002037817697-pat00002

Figure 112002037817697-pat00003
Figure 112002037817697-pat00003

(S)-1,4-벤조디옥산-2-카르복실산의 제조방법으로는 라세믹체를 디하이드로디에틸아민(dehydrodiethylamine)으로 분리하는 방법이 보고된 바 있으나 상기 방법은 수율이 약 1%로서 상업적 가치가 없는 방법이다. 2001년 미국의 세프라커(Sepracor)사는 미생물(Serratia marcescens) 유래의 에스테라제를 이용하여 높은 광학순도(99.8%ee)의 (S)-1,4-벤조디옥산-2-카르복실산을 제조하는 방법을 발표하였다(Tetrahedron: Asymmetry 12 (2001) 2169-2174). 상기 방법은 높은 광학 순도의 (S)-1,4-벤조디옥산-2-카르복실산을 제조할 수 있으나, 전체 수율이 21∼25% 정도로 낮고, 이 후 피페라진 염산염과 반응시키는 과정에서 원하지 않는 불순물인 디아미드가 약 10% 생성된다는 단점이 있다. As a method for preparing (S) -1,4-benzodioxane-2-carboxylic acid, a method of separating a racemic body with dihydrodiethylamine has been reported, but the method has a yield of about 1%. As such, there is no commercial value. In 2001, Sepracor, USA, used an esterase derived from Serratia marcescens to process (S) -1,4-benzodioxane-2-carboxylic acid of high optical purity (99.8% ee). A method of preparation has been published (Tetrahedron: Asymmetry 12 (2001) 2169-2174). The method can produce (S) -1,4-benzodioxane-2-carboxylic acid of high optical purity, but the overall yield is as low as 21-25%, and then in the process of reacting with piperazine hydrochloride The disadvantage is that about 10% of diamide, an unwanted impurity, is produced.

위와 같은 문제점을 해결하기 위해 세프라커사는 라세믹 1,4-벤조디옥산-2-카르복시피페라진을 D-타르타르산으로 분리하는 방법을 개발하였다(Tetrahedron: Asymmetry 12 (2001) 2169-2174). 이 방법 역시 높은 광학순도(99.3%ee)의 (S)- 1,4-벤조디옥산-2-카르복시피페라진을 제조할 수 있으나, 전체 수율이 약 20%로 낮고 여러 번의 재결정 과정을 거쳐야 하는 단점이 있다. In order to solve the above problems, Seppraker has developed a method of separating racemic 1,4-benzodioxane-2-carboxypiperazine into D-tartaric acid (Tetrahedron: Asymmetry 12 (2001) 2169-2174). This method can also produce high optical purity (99.3% ee) of (S) -1,4-benzodioxane-2-carboxypiperazine, but the overall yield is low at about 20% and requires several recrystallization processes. There are disadvantages.

전술한 문제점을 해결하기 위해, 간단한 공정을 이용하여 경제적으로 우수하며, 광학순도가 높은 광학활성 (S)-1,4-벤조디옥산-2-카르복시피페라진 또는 (S)-1,4-벤조디옥산-2-카르복실산을 생산할 수 있는 공정의 개발이 필요하다. In order to solve the above-mentioned problems, it is economically superior by using a simple process and high optical purity (S) -1,4-benzodioxane-2-carboxypiperazine or (S) -1,4- There is a need for development of a process that can produce benzodioxane-2-carboxylic acid.

이에, 본 발명자들은 세프라커사의 화학적 광학분할 방법과는 달리, 아직 보고되지 않은 효소나 미생물을 이용한 효소적 광학분할 방법, 좀 더 구체적으로, 프로테아제 효소를 이용하여 라세믹 1,4-벤조디옥산-2-카르복시피페라진을 광학활성 1,4-벤조디옥산-2-카르복시 화합물인 1,4-벤조디옥산-2-카르복시피페라진 및 1,4-벤조디옥산-2-카르복실산으로 분할하는 제조방법을 개발하였으며, 본 발명은 이에 기초하여 완성되었다. Therefore, the present inventors, unlike the chemical optical splitting method of Seppraker, enzymatic optical splitting method using an enzyme or microorganism that has not yet been reported, more specifically, racemic 1,4-benzodioxane using a protease enzyme 2-carboxypiperazines as optically active 1,4-benzodioxane-2-carboxylate compounds 1,4-benzodioxane-2-carboxypiperazin and 1,4-benzodioxane-2-carboxylic acid The manufacturing method of dividing was developed and the present invention was completed based on this.

따라서, 본 발명의 목적은 프로테아제 효소를 이용하여 라세믹 1,4-벤조디옥산-2-카르복시피페라진으로부터 광학활성 1,4-벤조디옥산-2-카르복시피페라진을 제조하는 방법을 제공하는데 있다.It is therefore an object of the present invention to provide a method for producing optically active 1,4-benzodioxane-2-carboxypiperazines from racemic 1,4-benzodioxane-2-carboxypiperazines using protease enzymes. have.

본 발명의 또 다른 목적은 프로테아제 효소를 이용하여 라세믹 1,4-벤조디옥산-2-카르복시피페라진으로부터 광학활성 1,4-벤조디옥산-2-카르복실산을 제조하는 방법을 제공하는데 있다.Another object of the present invention is to provide a method for preparing optically active 1,4-benzodioxane-2-carboxylic acid from racemic 1,4-benzodioxane-2-carboxypiperazin using a protease enzyme. have.

상기 목적을 달성하기 위한 본 발명의 제조방법은 pH 6∼8의 버퍼용액 존재 하에 미생물 유래의 프로테아제 효소를 이용하여 라세믹 1,4-벤조디옥산-2-카르복 시피페라진을 가수분해시키는 단계, 상기 반응액에 유기용매를 첨가하여 유기용매층과 수용액층으로 분리시키는 단계, 및 상기 유기용매 층으로부터 (S)-1,4-벤조디옥산-2-카르복시피페라진을 분리시키는 단계로 구성된다.The production method of the present invention for achieving the above object is to hydrolyze racemic 1,4-benzodioxane-2-carboxypiperazine using a protease enzyme derived from microorganisms in the presence of a buffer solution of pH 6-8 A step of separating an organic solvent layer and an aqueous solution layer by adding an organic solvent to the reaction solution, and separating (S) -1,4-benzodioxane-2-carboxypiperazine from the organic solvent layer It is composed.

상기 또 다른 목적을 달성하기 위한 본 발명의 제조방법은 pH 6∼8의 버퍼용액 존재 하에 미생물 유래의 프로테아제 효소를 이용하여 라세믹 1,4-벤조디옥산-2-카르복시피페라진을 가수분해시키는 단계, 상기 반응액에 유기용매를 첨가하여 유기용매층과 수용액층으로 분리시키는 단계, 및 상기 수용액 층으로부터 (R)-1,4-벤조디옥산-2-카르복실산을 분리시키는 단계로 구성된다.The production method of the present invention for achieving the above another object is to hydrolyze racemic 1,4-benzodioxane-2-carboxypiperazine using a protease enzyme derived from microorganisms in the presence of a buffer solution of pH 6-8 Comprising a step, separating the organic solvent layer and the aqueous solution layer by adding an organic solvent to the reaction solution, and separating (R) -1,4-benzodioxane-2-carboxylic acid from the aqueous solution layer do.

이하 본 발명을 좀 더 구체적으로 살펴보면 다음과 같다.Looking at the present invention in more detail as follows.

전술한 바와 같이, 본 발명에 따르면, 기질인 라세믹 1,4-벤조디옥산-2-카르복시피페라진을 pH 6∼8의 버퍼용액에 적절히 용해시킨 후, 아스퍼질러스(Aspergillus) 속 또는 스트렙토마이세스(Streptomyces) 속 미생물 유래의 프로테아제를 별도의 처리 공정 없이 첨가한 다음, 상기 반응 혼합물을 20∼40℃의 온도에서 100∼300rpm으로 교반시켜 (R)-이성질체만을 선택적으로 가수분해시킨다.As described above, according to the present invention, after dissolving racemic 1,4-benzodioxane-2-carboxypiperazine as a substrate in a buffer solution of pH 6 to 8, the genus Aspergillus or Streptococcus Proteases from the microorganism of the genus Steptomyces are added without further treatment, and then the reaction mixture is stirred at 100-300 rpm at a temperature of 20-40 ° C. to selectively hydrolyze only the (R) -isomer.

본 발명의 가수분해 반응 공정은 하기 반응식 1과 같다. The hydrolysis reaction process of the present invention is shown in Scheme 1 below.                     

Figure 112002037817697-pat00004
Figure 112002037817697-pat00004

이렇게 가수분해시킨 화합물에 유기용매를 첨가하여 유기용매층과 수용액층으로 구분하고, 상기 유기용매층으로부터 광학활성을 갖는 1,4-벤조디옥산-2-카르복시피페라진을 얻고, 상기 수용액층으로부터 광학활성을 갖는 1,4-벤조디옥산-2-카르복실산을 얻는다.An organic solvent was added to the compound hydrolyzed in this way, and the organic solvent layer was separated into an aqueous solution layer. From the organic solvent layer, 1,4-benzodioxane-2-carboxypiperazine having optical activity was obtained. 1,4-benzodioxane-2-carboxylic acid having optical activity is obtained.

한편, 본 발명에 사용되는 프로테아제는 아스퍼질러스(Aspergillus) 속 또는 스트렙토마이세스(Streptomyces) 속 미생물로부터 얻어지며, 상기 효소는 분말이나 액상 또는 담체로 고정화된 것 또는 효소를 함유하는 생물세포 및 고정화된 생물세포이다.On the other hand, the protease used in the present invention is obtained from a microorganism of the genus Aspergillus or Streptomyces, the enzyme is immobilized with a powder or liquid or carrier or biological cells containing the enzyme and immobilized Biological cells.

상기 아스퍼질러스(Aspergillus) 속 미생물로는 아스퍼질러스 멜레우스(Aspergillus melleus), 아스퍼질러스 소재(Aspergillus sojae), 아스퍼질러스 오리재(Aspergillus oryzae) 등이 있고, 스트렙토마이세스(Streptomyces) 속 미생물로는 스트렙토마이세스 그리세우스(Streptomyces griceus)가 있다. The Aspergillus (Aspergillus) in microorganisms are Aspergillus melre mouse (Aspergillus melleus), Aspergillus material (Aspergillus sojae), Aspergillus duck material (Aspergillus oryzae), etc., and Streptomyces (Streptomyces) in Microorganisms include Streptomyces griceus .

상기 프로테아제는 상업적으로 판매되는 것을 사용하거나 제조하여 사용할 수 있다. 상업적으로 판매되는 프로테아제는 예를 들어, 아마노(Amano)사의 프로테아제(Protease) P, 시그마(Sigma)사의 프로테아제 타입(Protease type) XIV, 프로테아제 타입(Protease type) XIX, 프로테아제 타입(Protease type) XXIII, 유로파(Europa)사의 유로파 프로테아제(Europa Protease) 6(Am) 등이 있으나, 이에 한정되는 것은 아니다. The protease may be used commercially available, or manufactured and used. Commercially available proteases include, for example, Protease P from Amano, Protease type XIV from Sigma, Protease type XIX, Protease type XXIII, Europa (Europa Protease) 6 (Am), etc., but is not limited thereto.

본 발명에 있어서, 효소 반응 온도는 20∼40℃가 바람직하며, 상기 온도가 20 ℃ 미만이면 반응 속도가 너무 느려지는 단점이 있고, 반응 온도가 40℃를 초과하면 광학순도가 떨어지는 문제점이 있다. 또한, 효소 반응시의 pH는 pH 6∼8의 범위가 적절하며, 상기 범위를 벗어날 경우 반응 속도가 느려지고 광학순도가 떨어지는 문제점이 있고, 가수분해 반응시 효소와 기질의 비율은 무게비로 1 : 1 ∼ 10 : 1이 바람직하며, 상기 범위를 벗어날 경우 반응속도가 너무 느려지거나 사용되는 효소의 양이 너무 많아 경제성이 떨어지는 문제점이 있다.In the present invention, the enzyme reaction temperature is preferably 20 to 40 ℃, if the temperature is less than 20 ℃ there is a disadvantage that the reaction rate is too slow, if the reaction temperature exceeds 40 ℃ there is a problem that the optical purity is lowered. In addition, the pH of the enzyme reaction is in the appropriate range of pH 6 ~ 8, if the outside the range of the reaction rate is slow and there is a problem that the optical purity falls, the ratio of enzyme and substrate in the hydrolysis reaction is 1: 1 by weight ratio. ~ 10: 1 is preferred, the reaction rate is too slow or out of the range or there is a problem that the economical efficiency is too much because the amount of the enzyme is used too much.

광학활성 1,4-벤조디옥산-2-카르복시피페라진은 다이셀(Daicel)사의 키랄 칼럼인 Chiralpak AD-H를 이용하여 R-폼과 S-폼을 쉽게 분석할 수 있으며, 광학활성 1,4-벤조디옥산-2-카르복실산의 분석은 역시 다이셀사의 키랄 칼럼인 Chiralcel OD-H를 써서 분석할 수 있다. Optically active 1,4-benzodioxane-2-carboxypiperazine can be easily analyzed for R-form and S-form using Chiralpak AD-H, a chiral column of Daicel Corporation. The analysis of 4-benzodioxane-2-carboxylic acid can be analyzed using Chiralcel OD-H, which is also Chiral's chiral column.

광학활성 1,4-벤조디옥산-2-카르복시피페라진의 경우, 0.1%의 디에틸아민(diethylamine)을 함유하고 있는 에탄올을 0.4㎖/분으로 흘리고, HPLC의 흡광도는 254nm로 하여 분석하면, (S)-1,4-벤조디옥산-2-카르복시피페라진의 머무름 시간(retention time)이 14.7분, (R)-1,4-벤조디옥산-2-카르복시피페라진의 머무름 시간이 17.6분으로 나타나 두 이성질체를 쉽게 구별할 수 있다. In the case of optically active 1,4-benzodioxane-2-carboxypiperazine, ethanol containing 0.1% diethylamine was poured at 0.4 ml / min, and the absorbance of HPLC was analyzed at 254 nm. The retention time of (S) -1,4-benzodioxane-2-carboxypiperazine is 14.7 minutes, and the retention time of (R) -1,4-benzodioxane-2-carboxypiperazine is 17.6. In minutes, the two isomers can be easily distinguished.

광학활성 1,4-벤조디옥산-2-카르복실산의 경우, 핵산, 이소프로판올 및 트리플루오로아세틱산(trifluoroacetic acid)의 혼합물을 95 : 5 : 0.1의 비율로 하여, 0.5㎖/분의 속도로 흘리고, HPLC의 흡광도는 254nm로 하여 분석하면, (S)-1,4-벤조디옥산-2-카르복실산의 머무름 시간이 42.5분, (R)-1,4-벤조디옥산-2-카르복실산의 머무름 시간이 53분으로 나타나 두 이성질체를 쉽게 구별할 수 있다. For optically active 1,4-benzodioxane-2-carboxylic acid, a mixture of nucleic acid, isopropanol and trifluoroacetic acid in a ratio of 95: 5: 0.1, at a rate of 0.5 ml / min When the absorbance of HPLC was 254 nm and analyzed, the retention time of (S) -1,4-benzodioxane-2-carboxylic acid was 42.5 minutes and (R) -1,4-benzodioxane-2. The retention time of the carboxylic acid is 53 minutes, making it easy to distinguish the two isomers.

이하 실시예를 통하여 본 발명을 좀 더 구체적으로 설명하지만 하기 예에 본 발명이 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples, but the present invention is not limited to the following examples.

실시예 1Example 1

100mM 인산용액(pH 7.0) 5㎖에 라세믹 1,4-벤조디옥산-2-카르복시피페라진의 염산염 0.1g(2중량%)을 넣고 pH를 7.0으로 조정한 다음, 미생물 또는 동물 유래의 가수분해 효소 0.1g(2중량%)을 넣고 30℃에서 반응을 수행하였다. 반응액 0.5㎖을 취해 10 ㎕의 10N 수산화나트륨용액과 잘 섞은 뒤에 1㎖의 에틸 아세테이트로 반응물을 추출해 위에서 언급한 분석방법으로 HPLC에서 분석한 결과 하기 표 1과 같은 결과를 얻었다. Into 5 ml of 100 mM phosphoric acid solution (pH 7.0), 0.1 g (2% by weight) of hydrochloric acid of racemic 1,4-benzodioxane-2-carboxypiperazine was added and pH was adjusted to 7.0. 0.1g (2% by weight) of the degrading enzyme was added thereto, and the reaction was performed at 30 ° C. 0.5 ml of the reaction solution was mixed with 10 μl of 10N sodium hydroxide solution, and then the reactant was extracted with 1 ml of ethyl acetate, and analyzed by HPLC using the aforementioned analytical method.

효 소enzyme 미 생 물microbe 광학순도(%ee)Optical purity (% ee) 아미드의 절대배열Absolute Arrangement of Amide 프로테아제Protease Aspergillusmelleus Aspergillus melleus 100100 SS Streptomycesgriceus Streptomyces griceus 9696 SS Aspergillusoryzae Aspergillus oryzae 93.893.8 SS Aspergillussojae Aspergillus sojae 80.880.8 SS Bacilluspolymax Bacillus polymax 23.123.1 SS Bacilluslicheniformis Bacillus licheniformis 27.827.8 SS Aspergillusniger Aspergillus niger 13.513.5 SS 아실리제Acylase Penicillium sp.Penicillium sp. 57.557.5 SS

상기 표 1에서, 아미드의 절대배열 S가 의미하는 바는 효소반응 결과, (R)-이성질체가 선택적으로 가수분해되어 반응물에 (S)-이성질체가 상대적으로 더 많이 남아있음을 의미하며, 광학순도가 높은 효소일수록 기질의 (R)-이성질체에 대한 선 택성이 높아 (S)-이성질체 화합물을 제조하는데 우수하다.In Table 1, the absolute sequence S of the amide means that the (R) -isomer is selectively hydrolyzed as a result of the enzymatic reaction, so that the (S) -isomer remains relatively more in the reactant, and the optical purity is The higher the enzyme, the higher the selectivity of the (R) -isomer of the substrate, the better the preparation of the (S) -isomer compound.

상기 표 1에 표시된 효소 외에 약 40종의 가수분해 효소를 이용하여 실험을 실시하였으나 대부분 선택성이 없거나 기질인 아미드를 가수분해하지 못하였다.Experiments were carried out using about 40 hydrolytic enzymes in addition to the enzymes shown in Table 1 above, but most of them did not hydrolyze amide, which is not selective or substrate.

실시예 2Example 2

실시예 1에서 선정된 효소 중 아스퍼질러스 멜레우스(Aspergillus melleus) 유래의 프로테아제를 사용하여 다음과 같은 반응을 수행하였다. 100mM 인산용액(pH 7.0) 350㎖에 라세믹 1,4-벤조디옥산-2-카르복시피페라진 7g(2중량%)을 넣고 pH를 7.0으로 조정한 다음, 상기 프로테아제 35g을 넣은 후 30℃에서 반응을 수행하였다. 반응 중의 pH는 20% 수산화나트륨용액을 이용하여 6.5∼7.5로 유지시켰다. 일정 시간마다 반응 샘플을 채취하여 반응 상황을 분석하였다. 49시간 반응 후 (S)-1,4-벤조디옥산-2-카르복시피페라진의 광학순도가 98.0%ee에 도달하였을 때, 반응을 중단시킨 후 반응액에 수산화나트륨용액을 첨가하여 pH를 8.0 이상으로 조정한 다음 에틸 아세테이트로 아미드를 추출하였다. 유기 용매층을 따로 분리하여 감압증류로 에틸 아세테이트를 제거한 결과, 2.8g의 (S)-1,4-벤조디옥산-2-카르복시피페라진을 회수하였다. 상부 유기용매층을 분리하고 남은 수용액에 염산용액을 첨가하여 pH를 2 이하로 낮춘 다음 에틸 아세테이트를 첨가하여 수용액상에 남아있는 가수분해된 (R)-1,4-벤조디옥산-2-카르복실산을 추출하였다. 이때 (R)-1,4-벤조디옥산-2-카르복실산의 광학순도는 95.1%ee였다. Among the enzymes selected in Example 1, the following reaction was carried out using a protease derived from Aspergillus melleus . To 350 ml of 100 mM phosphoric acid solution (pH 7.0) was added 7 g (2% by weight) of racemic 1,4-benzodioxane-2-carboxypiperazine, pH was adjusted to 7.0, and 35 g of the protease was added thereto. The reaction was carried out. The pH during the reaction was maintained at 6.5-7.5 using 20% sodium hydroxide solution. The reaction samples were taken at regular intervals to analyze the reaction situation. When the optical purity of (S) -1,4-benzodioxane-2-carboxypiperazine reached 98.0% ee after 49 hours of reaction, the reaction was stopped and sodium hydroxide solution was added to the reaction solution to adjust the pH to 8.0. After adjusting above, the amide was extracted with ethyl acetate. The organic solvent layer was separated and ethyl acetate was removed by distillation under reduced pressure, whereby 2.8 g of (S) -1,4-benzodioxane-2-carboxypiperazine was recovered. The upper organic solvent layer was separated and hydrochloric acid solution was added to the remaining aqueous solution to lower the pH to 2 or less, and then ethyl acetate was added to the remaining hydrolyzed (R) -1,4-benzodioxane-2-carboxate on the aqueous solution. Acid was extracted. At this time, the optical purity of (R) -1,4-benzodioxane-2-carboxylic acid was 95.1% ee.

실시예 3Example 3

실시예 2의 아스퍼질러스 멜레우스 유래의 프로테아제 대신 아스퍼질러스 오리재(Aspergillus oryzae) 유래의 프로테아제를 사용하여 반응을 실시하였다. 47시간 반응 후 (S)-1,4-벤조디옥산-2-카르복시피페라진의 광학순도가 89.9%ee였고, (R)-1,4-벤조디옥산-2-카르복실산의 광학순도는 88.9%ee를 나타내었다. 실시예 1에서와 같은 방법으로 (S)-1,4-벤조디옥산-2-카르복시피페라진을 회수한 후, 추출 용매를 감압증류로 제거하고 다시 톨루엔을 투입하여 가열하여 녹인 후 상온으로 냉각하는 방법으로 재결정을 2회 실시한 결과, 98%ee 이상의 (S)-1,4-벤조디옥산-2-카르복시피페라진을 얻을 수 있었다.The reaction was carried out using a protease derived from Aspergillus oryzae instead of the protease derived from Aspergillus meleus of Example 2. After 47 hours of reaction, the optical purity of (S) -1,4-benzodioxane-2-carboxypiperazine was 89.9% ee, and the optical purity of (R) -1,4-benzodioxane-2-carboxylic acid. Showed 88.9% ee. After recovering (S) -1,4-benzodioxane-2-carboxypiperazine in the same manner as in Example 1, the extraction solvent was removed by distillation under reduced pressure, and again toluene was added thereto to dissolve it and cooled to room temperature. As a result of recrystallization twice by the method described above, 98% ee or more of (S) -1,4-benzodioxane-2-carboxypiperazine was obtained.

실시예 4Example 4

실시예 2에서 얻은 광학순도 95.1%의 (R)-1,4-벤조디옥산-2-카르복실산을 회수한 후, 추출용매를 감압증류로 제거하고 다시 톨루엔을 사용하여 재결정한 결과, 광학순도 98% 이상의 (R)-1,4-벤조디옥산-2-카르복실산을 얻을 수 있었다.After recovering (R) -1,4-benzodioxane-2-carboxylic acid having an optical purity of 95.1% obtained in Example 2, the extraction solvent was removed by distillation under reduced pressure and recrystallized again using toluene. (R) -1,4-benzodioxane-2-carboxylic acid with a purity of 98% or more was obtained.

비교예 1Comparative Example 1

실시예 2의 반응 조건 중 온도를 50℃로 변경하여 반응을 실시하였다. 약 20시간 반응 후 반응이 더 이상 진행되지 않았다. 이때 (S)-1,4-벤조디옥산-2-카르복시피페라진의 광학순도는 21.6%ee로 나타나 실시예 2의 경우에 비추어 광학순도가 현저히 낮았다. The reaction was performed by changing the temperature to 50 degreeC among the reaction conditions of Example 2. After about 20 hours the reaction did not proceed anymore. At this time, the optical purity of (S) -1,4-benzodioxane-2-carboxypiperazine was 21.6% ee, which was significantly lower in light of Example 2.

비교예 2Comparative Example 2

실시예 2의 반응 조건 중 pH를 9.0으로 변경하여 반응을 실시하였다. 22시간 반응 후 (S)-1,4-벤조디옥산-2-카르복시피페라진의 광학순도는 9.4%ee였고, (R)-1,4-벤조디옥산-2-카르복실산의 광학순도는 72.4%ee로 나타나 실시예 2의 경우에 비추어 광학순도가 현저히 낮았다. The reaction was carried out by changing the pH to 9.0 among the reaction conditions of Example 2. After 22 hours of reaction, the optical purity of (S) -1,4-benzodioxane-2-carboxypiperazine was 9.4% ee, and the optical purity of (R) -1,4-benzodioxane-2-carboxylic acid. Was 72.4% ee, which was significantly lower in optical purity in the case of Example 2.

전술한 바와 같이, 본 발명의 방법은 미생물 유래의 프로테아제 효소를 사용하여 간단한 방법으로 높은 광학순도의 (S)-1,4-벤조디옥산-2-카르복시피페라진 및 (R)-1,4-벤조디옥산-2-카르복실산을 제조할 수 있었다. As described above, the method of the present invention is a high optical purity of (S) -1,4-benzodioxane-2-carboxypiperazine and (R) -1,4 by a simple method using protease enzymes derived from microorganisms. -Benzodioxane-2-carboxylic acid could be prepared.

Claims (8)

pH 6∼8의 버퍼용액 존재하에서,In the presence of a buffer solution of pH 6-8, 미생물 유래의 프로테아제 효소를 이용하여 라세믹 1,4-벤조디옥산-2-카르복시피페라진을 가수분해시키는 단계,Hydrolyzing racemic 1,4-benzodioxane-2-carboxypiperazin using a microbial protease enzyme, 상기 반응액에 유기용매를 첨가하여 유기용매층과 수용액층으로 분리시키는 단계, 및Adding an organic solvent to the reaction solution to separate the organic solvent layer and the aqueous solution layer, and 상기 유기용매 층으로부터 (S)-1,4-벤조디옥산-2-카르복시피페라진을 분리시키는 단계를 포함하는 것을 특징으로 하는 효소적 방법에 S-1,4-벤조디옥산-2-카르복시피페라진의 제조방법.S-1,4-benzodioxane-2-carboxy in an enzymatic method comprising the step of separating (S) -1,4-benzodioxane-2-carboxypiperazine from the organic solvent layer. Process for preparing piperazine. pH 6∼8의 버퍼용액 존재하에서,In the presence of a buffer solution of pH 6-8, 미생물 유래의 프로테아제 효소를 이용하여 라세믹 1,4-벤조디옥산-2-카르복시피페라진을 가수분해시키는 단계,Hydrolyzing racemic 1,4-benzodioxane-2-carboxypiperazin using a microbial protease enzyme, 상기 반응액에 유기용매를 첨가하여 유기용매층과 수용액 층으로 분리시키는 단계, 및Adding an organic solvent to the reaction solution to separate the organic solvent layer and the aqueous solution layer, and 상기 수용액 층으로부터 (R)-1,4-벤조디옥산-2-카르복실산을 분리시키는 것을 특징으로 하는 효소적 방법에 의한 광학활성 1,4-벤조디옥산-2-카르복실산의 제조방법.Preparation of optically active 1,4-benzodioxane-2-carboxylic acid by enzymatic method, characterized by separating (R) -1,4-benzodioxane-2-carboxylic acid from the aqueous solution layer Way. 제1항 또는 제2항에 있어서, 상기 프로테아제 효소는 분말, 액상 또는 담체로 고정화된 미생물 유래 프로테아제인 것을 특징으로 하는 방법.The method according to claim 1 or 2, wherein the protease enzyme is a microbial-derived protease immobilized in powder, liquid or carrier. 제1항 또는 제2항에 있어서, 상기 미생물은 아스퍼질러스(Aspergillus) 속 미생물 또는 스트렙토마이세스(Streptomyces) 속 미생물인 것을 특징으로 하는 방법.The method of claim 1 or 2, wherein the microorganism is a microorganism of the genus Aspergillus or a microorganism of the genus Streptomyces. 제4항에 있어서, 상기 아스퍼질러스(Aspergillus) 속 미생물은 아스퍼질러스 멜레우스(Aspergillus melleus), 아스퍼질러스 소재(Aspergillus sojae), 또는 아스퍼질러스 오리재(Aspergillus oryzae)인 것을 특징으로 하는 방법.The method of claim 4, wherein the Aspergillus (Aspergillus) in the microorganism, characterized in that Aspergillus melre mouse (Aspergillus melleus), Aspergillus material (Aspergillus sojae), or Aspergillus duck material (Aspergillus oryzae) Way. 제4항에 있어서, 상기 스트렙토마이세스(Streptomyces) 속 미생물은 스트렙토마이세스 그리세우스(Streptomyces griceus)인 것을 특징으로 하는 방법.The method of claim 4, wherein the Streptomyces genus microorganism is Streptomyces griceus . 제1항 또는 제2항에 있어서, 상기 가수분해 반응의 온도는 20∼40℃인 것을 특징으로 하는 방법.The method of claim 1 or 2, wherein the temperature of the hydrolysis reaction is 20 to 40 ℃. 제1항 또는 제2항에 있어서, 상기 가수분해 반응의 효소와 기질의 비율은 무게비로 1 : 1 ∼ 10 : 1인 것을 특징으로 하는 방법.The method according to claim 1 or 2, wherein the ratio of the enzyme and the substrate in the hydrolysis reaction is 1: 1 to 10: 1 by weight.
KR1020020071242A 2002-11-15 2002-11-15 Method for preparing an optical active 1,4-benzodioxan-2-carboxylic compounds by enzymatic method KR100651337B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020020071242A KR100651337B1 (en) 2002-11-15 2002-11-15 Method for preparing an optical active 1,4-benzodioxan-2-carboxylic compounds by enzymatic method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020071242A KR100651337B1 (en) 2002-11-15 2002-11-15 Method for preparing an optical active 1,4-benzodioxan-2-carboxylic compounds by enzymatic method

Publications (2)

Publication Number Publication Date
KR20040042665A KR20040042665A (en) 2004-05-20
KR100651337B1 true KR100651337B1 (en) 2006-11-28

Family

ID=37339430

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020071242A KR100651337B1 (en) 2002-11-15 2002-11-15 Method for preparing an optical active 1,4-benzodioxan-2-carboxylic compounds by enzymatic method

Country Status (1)

Country Link
KR (1) KR100651337B1 (en)

Also Published As

Publication number Publication date
KR20040042665A (en) 2004-05-20

Similar Documents

Publication Publication Date Title
JP3010497B2 (en) Method for producing optically active α-hydroxyesters
EP2360160A1 (en) Intermediates and their use for producing benzoxazine derivative
KR100651337B1 (en) Method for preparing an optical active 1,4-benzodioxan-2-carboxylic compounds by enzymatic method
US5858737A (en) Conversion of indene to (1S)-amino-(2R)-indanol free of any stereoisomer, by combination of dioxygenase bioconversion and chemical steps
US7168937B2 (en) Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives
JPWO2004108944A1 (en) Method for producing optically active chromancarboxylic acid ester
US8546114B2 (en) Processes for the preparation of optically active cyclopentenones and cyclopentenones prepared therefrom
JP4601621B2 (en) Method for producing (S) -indoline-2-carboxylic acid and (S) -indoline-2-carboxylic acid methyl ester compound using hydrolase
KR101399551B1 (en) Processes for the preparations of optically active cyclopentenones and cyclopentenones prepared therefrom
KR100378741B1 (en) Method for preparing R- or S-form α-substituted heterocyclic carboxyl acid and counter enantiomeric form of α-substituted heterocyclic carboxyl acid ester thereto using enzyme
EP1811037B1 (en) Optically active cyclopentenones for use in the peparation of prostaglandins
KR100368735B1 (en) Method for preparing R- or S-form α-substituted heterocyclic carboxyl acid using enzyme
EP1705252B1 (en) Method for producing optically active N-protected-propargylglycine
WO1999004028A1 (en) PROCESS FOR PREPARING OPTICALLY ACTIVE α-TRIFLUOROMETHYLLACTIC ACID AND ANTIPODE ESTERS THEREOF AND METHOD OF PURIFICATION THEREOF
KR100688770B1 (en) Method for preparing an optically active R-2-amino-1-butanol by enzymatic method
JP3741758B2 (en) Process for producing optically active glycerol derivatives
WO2007039079A1 (en) Process for the synthesis of beta amino acids
US6171832B1 (en) Process for the preparation cis-(1S,2R)-indanediol by direduction of 1,2-indanedione using trichosporon cutaneum
JP2006050990A (en) Method for producing optically active 2-substituted-3-(4-substituted oxyphenyl)propionic acid and its antipodal ester
JP4834208B2 (en) Method for producing (2S, 3R) -2,3-epoxybutyric acid ester
JP2001046076A (en) Production of (r)-2-amino-1-phenylethanol or its halogen substitution compound
KR100973710B1 (en) The method for preparing optically active n-substituted phenylglycine alkyl esters by enzymatic method
JP4746019B2 (en) Optically active β-cyanoisobutyric acid and process for producing the same
JP4565672B2 (en) Optically active β-cyanoisobutyric acid and process for producing the same
Wei et al. Chemoenzymatic synthesis of Ro 25-8210 and Ro 25-6630

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20091106

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee